Bandini, Cecilia
Mereu, Elisabetta
Paradzik, Tina
Labrador, Maria
Maccagno, Monica
Cumerlato, Michela
Oreglia, Federico
Prever, Lorenzo
Manicardi, Veronica
Taiana, Elisa
Ronchetti, Domenica
D’Agostino, Mattia
Gay, Francesca
Larocca, Alessandra
Besse, Lenka
Merlo, Giorgio Roberto
Hirsch, Emilio
Ciarrocchi, Alessia
Inghirami, Giorgio
Neri, Antonino
Piva, Roberto
Funding for this research was provided by:
Università degli Studi di Torino
Article History
Received: 30 May 2023
Accepted: 3 August 2023
First Online: 10 August 2023
Change Date: 5 October 2023
Change Type: Update
Change Details: The original online version of this article was revised: Funding note removed
Declarations
:
: PBMCs from healthy blood donors and BM aspirates of MM patients were kindly provided by the local Blood Bank (Città Della Salute e della Scienza Hospital, Turin). Informed consent was obtained from all enrolled patients after the procedures were approved by the local ethical committee (“Validation of new pharmacological synergies in multiple myeloma” (00143/2022)). All animal experiments were authorized by the Ethical Committee of the University of Torino and the Italian Ministry of Health.
: Not applicable.
: The authors declare that they have no competing interests.